These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22972701)

  • 1. The solution properties of mefenamic acid and a closely related analogue are indistinguishable in polar solvents but significantly different in nonpolar environments.
    Lee EH; Byrn SR; Pinal R
    J Pharm Sci; 2012 Dec; 101(12):4529-39. PubMed ID: 22972701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of metastable flufenamic acid by inclusion of mefenamic acid: solid solution or epilayer?
    Lee EH; Byrn SR
    J Pharm Sci; 2010 Sep; 99(9):4013-22. PubMed ID: 20589947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive-induced metastable single crystal of mefenamic acid.
    Lee EH; Byrn SR; Carvajal MT
    Pharm Res; 2006 Oct; 23(10):2375-80. PubMed ID: 16927183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic study of the transformation of mefenamic acid polymorphs in various solvents and under high humidity conditions.
    Kato F; Otsuka M; Matsuda Y
    Int J Pharm; 2006 Sep; 321(1-2):18-26. PubMed ID: 16765543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow-injection spectrofluorimetric determination of flufenamic and mefenamic acid in pharmaceuticals.
    Albero MI; Sanchez-Pedreño C; Garcia MS
    J Pharm Biomed Anal; 1995 Aug; 13(9):1113-7. PubMed ID: 8573636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studying of drug solubility in water and alcohols using drug-ammonium ionic liquid-compounds.
    Halayqa M; Pobudkowska A; Domańska U; Zawadzki M
    Eur J Pharm Sci; 2018 Jan; 111():270-277. PubMed ID: 28986197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubility behavior of polymorphs I and II of mefenamic acid in solvent mixtures.
    Romero S; Escalera B; Bustamante P
    Int J Pharm; 1999 Feb; 178(2):193-202. PubMed ID: 10205639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermodynamic properties of flufenamic and niflumic acids--specific and non-specific interactions in solution and in crystal lattices, mechanism of solvation, partitioning and distribution.
    Perlovich GL; Surov AO; Bauer-Brandl A
    J Pharm Biomed Anal; 2007 Nov; 45(4):679-87. PubMed ID: 17336023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of uniform particles of flufenamic acid and its calcium and barium salts.
    Mohamed AA; Matijević E
    J Colloid Interface Sci; 2012 Sep; 381(1):198-201. PubMed ID: 22703985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubilization and determination of solution thermodynamic properties of itraconazole in different solvents at different temperatures.
    Jagdale SK; Nawale RB
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1168-1180. PubMed ID: 30935249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II).
    Kovala-Demertzi D; Hadjipavlou-Litina D; Staninska M; Primikiri A; Kotoglou C; Demertzis MA
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):742-52. PubMed ID: 18720191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary multianalytical approach to study the distinctive structural features of the main humic fractions in solution: gray humic acid, brown humic acid, and fulvic acid.
    Baigorri R; Fuentes M; González-Gaitano G; García-Mina JM; Almendros G; González-Vila FJ
    J Agric Food Chem; 2009 Apr; 57(8):3266-72. PubMed ID: 19281175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubility enhancement of simvastatin by arginine: thermodynamics, solute-solvent interactions, and spectral analysis.
    Meor Mohd Affandi MM; Tripathy M; Shah SA; Majeed AB
    Drug Des Devel Ther; 2016; 10():959-69. PubMed ID: 27041998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubility of sparingly soluble drug derivatives of anthranilic acid.
    Domańska U; Pobudkowska A; Pelczarska A
    J Phys Chem B; 2011 Mar; 115(11):2547-54. PubMed ID: 21366210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubility and molecular interactions of ferulic acid in various (isopropanol + water) mixtures.
    Haq N; Siddiqui NA; Shakeel F
    J Pharm Pharmacol; 2017 Nov; 69(11):1485-1494. PubMed ID: 28722130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-state characterization of mefenamic acid.
    Panchagnula R; Sundaramurthy P; Pillai O; Agrawal S; Raj YA
    J Pharm Sci; 2004 Apr; 93(4):1019-29. PubMed ID: 14999737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of temperature on the solubilization of thiabendazole by combined action of solid dispersions and co-solvents.
    Muela S; Escalera B; Peña MA; Bustamante P
    Int J Pharm; 2010 Jan; 384(1-2):93-9. PubMed ID: 19819314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of solubility profiles of eflucimibe polymorphs: experimental and modeling.
    Teychene S; Autret JM; Biscans B
    J Pharm Sci; 2006 Apr; 95(4):871-82. PubMed ID: 16489606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism in sulfadimidine/4-aminosalicylic acid cocrystals: solid-state characterization and physicochemical properties.
    Grossjohann C; Serrano DR; Paluch KJ; O'Connell P; Vella-Zarb L; Manesiotis P; Mccabe T; Tajber L; Corrigan OI; Healy AM
    J Pharm Sci; 2015 Apr; 104(4):1385-98. PubMed ID: 25605031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of solute rejection in solvent resistant nanofiltration: the effect of solvent on solute rejection.
    Darvishmanesh S; Degrève J; Van der Bruggen B
    Phys Chem Chem Phys; 2010 Oct; 12(40):13333-42. PubMed ID: 20842303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.